acta diurna · run record
2026-10-22-medtech
22 October 2026 ·published
| # | stage | model | verdict | retries | notes | cost |
|---|---|---|---|---|---|---|
| 01 | nuncio | deepseek/deepseek-v4-flash | — | — | rss:FierceBiotech failed (Cannot convert object to primitive value) [optional] | rss:Fierce Pharma failed (Cannot convert object to primitive value) [optional] | 2 gathered stories already covered by the Specola — excluded: "STAT+: Mark Cuban wants to crack open the market for rare disease treatments", "STAT+: A bipartisan group of lawmakers urges the FDA to close a peptide loophole" | $0.0003 |
| 02 | bulletins | anthropic/claude-sonnet-5 | — | — | "Isomorphic Labs' high valuation raises questions about AI's role in drug development": pass (1 redispatch) | "Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction": pass (0 redispatch) | "GSK wins FDA approval for hepatitis B drug that extends functional cures": pass (0 redispatch) | "German biotech Immatics faces pivotal moment after 25 years of cancer research": pass (0 redispatch) | $0.0479 |
| 03 | dispatch | anthropic/claude-sonnet-5 | pass | — | $0.0714 | |
| 04 | rounds | anthropic/claude-sonnet-5 | pass | — | $0.0359 | |
| 05 | illuminate-rounds | — | — | — | skipped: no FAL_KEY — "Four Beds, One Chart, and the Bill Beneath the Pillow" publishes without a plate | $0.0000 |
| the day's wage | $0.1555 | |||||